A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells
about
Smart nanosystems: Bio-inspired technologies that interact with the host environmentPDBe: improved accessibility of macromolecular structure data from PDB and EMDBEnhancement of MHC-I antigen presentation via architectural control of pH-responsive, endosomolytic polymer nanoparticles.Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapyCurrent status and perspectives of patient-derived xenograft models in cancer research.Impact of Conditional miRNA126 Overexpression on Apoptosis-Resistant Endothelial Cell Production.Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins.Selective peptide inhibitors of antiapoptotic cellular and viral Bcl-2 proteins lead to cytochrome c release during latent Kaposi's sarcoma-associated herpesvirus infection.A Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 HomologComputational design and experimental verification of a symmetric protein homodimer.Rosetta:MSF: a modular framework for multi-state computational protein design.Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer.The Bcl-2 family: structures, interactions and targets for drug discovery.Engineering CAR-T cells: Design concepts.Algorithms for protein design.Designing helical peptide inhibitors of protein-protein interactionsDeep sequencing methods for protein engineering and design.Tuning DNA binding affinity and cleavage specificity of an engineered gene-targeting nuclease via surface display, flow cytometry and cellular analyses.Structural basis of apoptosis inhibition by the fowlpox virus protein FPV039.Rational design of TNFα binding proteins based on the de novo designed protein DS119.AbDesign: An algorithm for combinatorial backbone design guided by natural conformations and sequences.The Bcl-2 Family in Host-Virus Interactions.GFP-complementation assay to detect functional CPP and protein delivery into living cells.Massively parallel de novo protein design for targeted therapeutics.Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets.Creation of artificial protein-protein interactions using α-helices as interfaces.High-throughput characterization of protein-protein interactions by reprogramming yeast mating.PixelDB: Protein-peptide complexes annotated with structural conservation of the peptide binding mode.Enzyme-Cleavable Polymeric Micelles for the Intracellular Delivery of Proapoptotic Peptides.The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It.Recent developments in intracellular protein delivery.Engineering altered protein-DNA recognition specificity.Protein design: from computer models to artificial intelligencecoiled-coil peptides as scaffolds for disrupting protein-protein interactionsDesigned for life: biocompatible de novo designed proteins and components
P2860
Q26776370-523EB43A-9238-4513-9C87-B928EDC2DEF7Q30488435-7A181475-6FB6-4FCB-B438-3E1DE7A7A036Q30877907-6D79B644-D905-4FCA-82B2-3881F1F09552Q30878158-8AD73E63-048C-4B17-89EE-F3493F794AF4Q33667686-33C46999-0B16-4CA7-AC22-5CC7ED2A9961Q35626844-21352812-F5A2-45EC-AAB3-DB9675059B50Q35640928-8044A66F-1757-41C7-874D-DD6C40754567Q35802945-7E82BEFF-BC35-418C-99F3-2A2221FF2EFCQ35901611-57B3CE3B-D79B-4433-B389-DA67E634F955Q36008440-59B96BE8-11D9-4A30-8EE4-FD13864BD156Q36399033-9D2459A0-3E6D-4EDF-8FB2-A02B0AD214EEQ37452081-AEB56DFE-C7CC-466B-969F-EE2FF76F5B8BQ38268329-9D81D7E9-609D-4C69-AED0-CCF35A273B58Q38290031-DFFD7D38-292B-4E9D-B409-B484E589CDEAQ38810159-CBAF2D0D-79B4-43C2-BC0A-46D52DB6E953Q38819761-5C3E63FE-EC00-4766-AB58-E80B45BC8015Q39019516-DDF8B4E1-8D50-4F9E-846F-97DC63C71464Q40057209-9B3C78A9-A2E0-4640-8877-6A7C07CFBE0FQ40241754-6D6C3B43-A321-44D6-B842-45456F03FC6FQ40519349-170455AE-8119-4624-814E-E546797BA14FQ41451876-03FC141D-CFAC-4672-AA08-FC288783DB5AQ41922877-63D666F5-8F98-4D81-9264-59603A65DEF5Q42652037-F1A241D9-21DE-4955-A4B6-43AE439BA166Q46331477-EC80716C-897E-45D2-A696-65AB721814CDQ47133162-91850A87-5D27-458C-9525-C4B371F989F8Q47321018-3C53EA1A-CA7A-431E-AF47-6AC17AFA9962Q47395470-243204FD-8891-410C-9E48-5EA80657C937Q47565095-89C3AFFE-BE26-4A50-A5D0-E5053AE250E3Q48145247-0C7F829E-FFD7-4EA3-95FC-F08D1E190869Q52349005-9F21026D-7423-4033-BB52-5BA10B1047DFQ52682952-BC7F7B32-BF85-47F9-9977-311E744BCF7FQ55359800-A235BA71-4788-4229-A076-7BB843FD015AQ57794249-401B9664-D89F-42E7-A3F9-13E837A8F382Q58565946-81A1063D-B4CE-45AB-9CE2-246EC5088A66Q58693720-0EB76EB3-2CE9-40F5-9AA6-ED8966596420
P2860
A Computationally Designed Inhibitor of an Epstein-Barr Viral Bcl-2 Protein Induces Apoptosis in Infected Cells
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A Computationally Designed Inh ...... es Apoptosis in Infected Cells
@ast
A Computationally Designed Inh ...... es Apoptosis in Infected Cells
@en
A Computationally Designed Inh ...... es Apoptosis in Infected Cells
@nl
type
label
A Computationally Designed Inh ...... es Apoptosis in Infected Cells
@ast
A Computationally Designed Inh ...... es Apoptosis in Infected Cells
@en
A Computationally Designed Inh ...... es Apoptosis in Infected Cells
@nl
prefLabel
A Computationally Designed Inh ...... es Apoptosis in Infected Cells
@ast
A Computationally Designed Inh ...... es Apoptosis in Infected Cells
@en
A Computationally Designed Inh ...... es Apoptosis in Infected Cells
@nl
P2093
P2860
P50
P921
P1433
P1476
A Computationally Designed Inh ...... es Apoptosis in Infected Cells
@en
P2093
Anthony J Convertine
Barry L Stoddard
Betty W Shen
Bruno E Correia
Daciana Margineantu
David M Hockenbery
Garrett Booth
Geoffrey Y Berguig
Patrick S Stayton
Shani Frayo
P2860
P304
P356
10.1016/J.CELL.2014.04.034
P407
P577
2014-06-19T00:00:00Z